GLP-1 receptor drugs for Obesity
34 tracked GLP-1 receptor drugs in the Obesity race. The class explanation lives on the GLP-1 receptor page; the full indication pipeline across every mechanism is on the Obesity page.
4 approved / phase 416 Phase 31 Phase 2/36 Phase 27 Phase 1
Head-to-head evidence: ASC30 vs BMF-650 · ASC30 vs Berobenatide · ASC30 vs Bofanglutide · ASC30 vs DA-302168S · ASC30 vs DehydraTECH-CBD/semaglutide · ASC30 vs Ecnoglutide (VRB-101)